ED vs EW · P/E 18, rev $15.26B vs P/E 47, rev $1.39B
Consolidated Edison Inc (ED) versus Edwards Lifesciences Corp (EW) — a side-by-side from cached financials, not a winner call.
Consolidated Edison Inc (ED) is a utilities - regulated electric company listed on US.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Latest reported ED revenue for 2024-12-31 was $15.26B. Net income was $1.82B. Revenue was up 4.0% from 2023-12-31 to 2024-12-31. ED currently screens at market cap $36.02B and trailing P/E 18.3.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
ED currently screens at market cap $36.02B and trailing P/E 18.3. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Not investment advice. Open the ED and EW stock pages for the full models.
Not investment advice.